![Thomas Biancardi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Biancardi
Career history of Thomas Biancardi
Former positions of Thomas Biancardi
Companies | Position | Start | End |
---|---|---|---|
PFIZER, INC. | Corporate Officer/Principal | - | - |
IVERIC BIO, INC. | Chief Operating Officer | 31/08/2007 | 30/01/2012 |
Investor Relations Contact | 28/08/2013 | 13/01/2015 | |
Public Communications Contact | 31/08/2007 | - | |
Corporate Officer/Principal | 18/08/2013 | - | |
Oldtech, Inc.
![]() Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Chief Operating Officer | - | - |
Director of Finance/CFO | - | - |
Training of Thomas Biancardi
New York University | Masters Business Admin |
Rutgers State University of New Jersey | Undergraduate Degree |
Statistics
International
United States | 6 |
Operational
Chief Operating Officer | 2 |
Corporate Officer/Principal | 2 |
Masters Business Admin | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PFIZER, INC. | Health Technology |
Private companies | 2 |
---|---|
Oldtech, Inc.
![]() Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
IVERIC bio, Inc.
![]() IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
- Stock Market
- Insiders
- Thomas Biancardi
- Experience